Word: zerit
(lookup in dictionary)
(lookup stats)
Dates: during 2000-2009
Sort By: most recent first
(reverse)
...early 1990s, Yale researchers discovered a compound, d4T, that slows the progression of HIV. Yale licensed an exclusive patent for the drug to pharmaceutical giant Bristol-Myers Squibb, which then marketed it under the brand name Zerit...
...university earned about $30 million a year from Zerit, Yale’s president Richard C. Levin told the school’s alumni magazine this month. Yale later sold off its remaining rights to the discovery to a group of investors for “a lump sum in excess of $100 million,” Levin added...
...message may be getting through. Last month Merck and Bristol-Myers Squibb slashed the price offered to African countries for anti-AIDS "cocktails" to a fraction of what's charged in industrialized countries. One Bristol-Myers AIDS drug, Zerit, now costs just $54 a year in Africa; in the U.S., patients pay $3,589. This month, six other firms assured U.N. Secretary-General Kofi Annan they too would continue lowering prices. But at a conference in Norway last week with officials from the World Health Organization and World Trade Organization, some industry leaders resisted calls for further discounts. Said Bill...
Whether out of sheer benevolence or a desire to end its public relations woes, Bristol-Meyers-Squibb Pharmaceuticals announced last week that it would market its AIDS drugs, Zerit and Videx, to Africa at a combined price of $1 per day. This follows closely on the heels of Merck Pharmaceuticals' announcement that it would market its drug, the protease inhibitor Crixivan, to Africa at the reduced price of $600 per year. AIDS drugs typically cost between $10,000 and $15,000 per year. Needless to say, because of these exorbitantly high prices, these drugs are out of reach for those...